Stockscreener 앱 받기
0.6522
5.29%
-0.0364
전일 마감가:
$0.6886
열려 있는:
$0.6863
하루 거래량:
135.34K
Relative Volume:
0.47
시가총액:
$29.23M
수익:
$106.79M
순이익/손실:
$-8.73M
주가수익비율:
-3.261
EPS:
-0.2
순현금흐름:
$10.81M
1주 성능:
+1.89%
1개월 성능:
-44.73%
6개월 성능:
-76.28%
1년 성능:
-85.18%
1일 변동 폭
$0.65
$0.7173
1주일 범위
$0.602
$0.73
52주 변동 폭
$0.602
$4.70
Harvard Bioscience Inc Stock (HBIO) Company Profile
명칭
Harvard Bioscience Inc
전화
(508) 893-8999
주소
84 OCTOBER HILL RD, HOLLISTON, MA
HBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.6501 | 29.23M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
493.11 | 176.29B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
230.98 | 66.56B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.34 | 44.95B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
221.25 | 32.81B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
33.73 | 17.41B | 17.28B | 108.00M | 391.00M | 0.20 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-10 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | 개시 | Northland Capital | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-01-24 | 재확인 | Janney | Buy |
| 2018-01-23 | 재확인 | The Benchmark Company | Buy |
| 2016-11-17 | 개시 | Singular Research | Buy |
| 2015-07-28 | 개시 | The Benchmark Company | Buy |
모두보기
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges - Investing.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Harvard Bioscience Reports 2024 Financial Results - TipRanks
Harvard Bioscience Navigates Growth Amid Challenges - TipRanks
Harvard Bioscience secures waiver for credit covenant By Investing.com - Investing.com Australia
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 - GlobeNewswire
Harvard Bioscience CEO to Host Fireside Chats at Roth and KeyBanc Healthcare Forums - StockTitan
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire
Earnings call transcript: Harvard Bioscience Q4 2024 beats expectations but faces market challenges - Investing.com
Harvard Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Harvard Bioscience slumps after weak revenue forecast - TradingView
HARVARD BIOSCIENCE Earnings Results: $HBIO Reports Quarterly Earnings - Nasdaq
Harvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last year - TipRanks
Harvard Bioscience earnings beat, revenue topped estimates By Investing.com - Investing.com UK
Harvard Bioscience Achieves Profit Turnaround Despite Revenue Challenges in Latest Quarter - StockTitan
Harvard Bioscience IncQ4 2024 Revenues $24.6 Million -March 12, 2025 at 07:04 am EDT - Marketscreener.com
Harvard Bioscience Q4 and Full-Year 2024 Financial Results - TradingView
Harvard Bioscience secures waiver for credit covenant - Investing.com
Harvard BioscienceExploring Alternative Capital Sources For Refinancing Outstanding Indebtedness By June 30 - Marketscreener.com
Costco Price Plunge Equals Opportunity for Investors - The Globe and Mail
Harvard Bioscience (HBIO) Expected to Announce Earnings on Wednesday - Armenian Reporter
Harvard Bioscience, Inc. to Host Earnings Call - ACCESS Newswire
HBIO stock touches 52-week low at $0.86 amid market challenges - Investing.com Australia
BioAtla Inc (BCAB) shows promising results - US Post News
Dycom Industries, Inc. to Participate in Upcoming Investor Conferences - The Manila Times
Harvard Bioscience to Showcase Latest Solutions for - GlobeNewswire
Can These New Research Platforms Transform Toxicology Studies? Harvard Bioscience Reveals Latest Innovations - StockTitan
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET - The Manila Times
Harvard Bioscience, Inc. to Announce Q4 2024 Financial Results on March 12, 2025 - Nasdaq
How to Access Harvard Bioscience's Critical Q4 2024 Financial Results Call - StockTitan
5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - MSN
NAYA Biosciences Announces Nomination of New Board Members - The Manila Times
Harvard Bioscience stock hits 52-week low at $1.23 By Investing.com - Investing.com Canada
BostInno✈️ Net-zero aviation fuel | MassVentures' deep tech investments - The Business Journals
HBIO stock touches 52-week low at $1.3 amid sharp annual decline - Investing.com Australia
Preclinical Software for Physiology DA and AS Market to Grow by USD 4.38 Billion from 2025-2029, Driven by Bioinformatics Tools in Research, AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Electroporation Instruments Market Growth 2025: Key Industry Trends, Share and Demand by 2033 - WICZ
Harvard Bioscience Inc (HBIO) Stock Sees a-10.84 Decrease - The News Heater
OceanFirst Financial Corp (OCFC) vs. Its Peers: A Comparison - The News Heater
Why Investors Shouldn't Be Surprised By Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 31% Share Price Plunge - Simply Wall St
Harvard Bioscience, Inc. (NASDAQ:HBIO) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough - Simply Wall St
JPMorgan Chase & Co. Makes New $75,000 Investment in WEBTOON Entertainment Inc. (NASDAQ:WBTN) - Defense World
JPMorgan Chase & Co. Boosts Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.7 amid market challenges - Investing.com India
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 22.8% in January - MarketBeat
Harvard Bioscience Inc (HBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Harvard Bioscience Inc 주식 (HBIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Green James W | Chief Executive Officer |
Jun 06 '24 |
Buy |
3.07 |
20,000 |
61,400 |
3,101,091 |
1.12%
0.04%
자본화:
|
볼륨(24시간):